Cell Care

Cell Care Therapeutics, founded in 2014, is a biotechnology company. The company is developing regenerative immunotherapies, which involve novel biologics derived from the secretions of adult stem cells. These secretions consist of a complex array of natural therapeutic components, including proteins, exosomes, and microRNAs, collectively known as the "secretome." The secretome contains anti-inflammatory and pro-regenerative molecules, which are expected to reverse inflammatory processes while stimulating tissue regeneration. Cell Care has assembled a robust team of in-house scientists, world-class consultants, and manufacturing experts to advance this technology into clinical stages for the treatment of severe inflammatory and degenerative eye diseases that may lead to vision loss.